0 By jay In Press ReleasesPosted November 25, 2020Axial Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceNovember 25, 2020 READ MORE
0 By jay In Press ReleasesPosted November 16, 2020Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci CapitalNovember 16, 2020 READ MORE
0 By jay In Press ReleasesPosted September 22, 2020Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical ScienceSeptember 22, 2020 READ MORE
0 By jay In Press ReleasesPosted September 15, 2020Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember, 15, 2020 READ MORE
0 By jay In Press ReleasesPosted August 17, 2020Axial Biotherapeutics to Present at The JMP Securities CNS ForumAugust 12, 2020 READ MORE
1 By jay In Press ReleasesPosted July 28, 2020Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease TherapeuticsJuly 28, 2020 READ MORE
0 By jay In Press ReleasesPosted May 27, 2020Axial Biotherapeutics to Present at the Jefferies Virtual Global Healthcare ConferenceMay 27, 2020 READ MORE
0 By jay In Press ReleasesPosted May 22, 2020Axial Biotherapeutics to Present Virtual Presentation at American Society of Clinical Psychopharmacology (ASCP) 2020 Annual MeetingMay 22, 2020 READ MORE
2 By jay In Press ReleasesPosted April 2, 2020Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum DisorderApril 02, 2020 READ MORE
0 By jay In Press ReleasesPosted March 13, 2020Axial Biotherapeutics to Present at the Chardan 2nd Annual Microbiome Medicines Virtual SummitMarch 10, 2020 READ MORE
